Multiple Sclerosis and Migraine
Migraine, a common comorbidity in multiple sclerosis (MS) is not part of the MS prodrome, new research suggested.
Migraine, a common comorbidity in multiple sclerosis (MS) is not part of the MS prodrome, new research suggested.
When evaluated at 3 or 12 months, serum neurofilament light chain (sNfL) levels were predictive of new or enlarging T2 lesions in patients with multiple sclerosis (MS) regardless of treatment assignment, new sub-study data from the ASCLEPIOS I/II trials showed.
In a new study, patients with carotid artery plaque in which microplastics and nanoplastics were detected had a higher risk for death or major cardiovascular events than those with plaques where particles were not found.
In a new study published in The New England of Medicine,Hampshire et al. bring clarity to how SARS-CoV-2 infection may affect cognition.
The prevalence of cannabis use has increased from 10% in 2002 to 18% in 2019 among US adults. The number of cases of cannabis disorder has also increased sharply over time in the US. This could be because of the decreasing perception of the harmfulness of cannabis use in the general population. National surveys find that the percentage of people...
Researchers have pioneered a study using virtual reality (VR) to identify early signs of Alzheimer's disease through impaired spatial navigation in asymptomatic adults at risk.
For children and teens, irregular meals such as skipped breakfasts are linked to an increased risk of frequent headaches, according to a new study published in the February 28, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
New research suggests a high-sugar diet, commonly associated with obesity, leads to insulin resistance in the brain and may heighten the risk of neurodegenerative diseases like Alzheimer's.
People with higher exposure to traffic-related air pollution were more likely to have high amounts of amyloid plaques in their brains associated with Alzheimer's disease after death, according to a new study.
A simple blood test to diagnose Alzheimer's disease ( the ptau-217 blood test) soon may replace more invasive and expensive screening methods such as spinal taps and brain scans.